Oxidative stress and memory decline in adults with down syndrome: Longitudinal study

Journal of Alzheimer's Disease

Volumn 31, Issue 2, 2012, Pages 277-283

  Zis, Panagiotis ^a   Dickinson, Mark ^b   Shende, Sima ^c   Walker, Zuzana ^a   Strydom, Andre ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Enfield Integrated Learning Disability Team   (United Kingdom)

^c Taylor Centre   (United Kingdom)

Author keywords

Aging; Alzheimer's disease; Down syndrome; memory; oxidative stress; superoxide dismutase

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE PEROXIDASE; SUPEROXIDE DISMUTASE;

ADAPTIVE BEHAVIOR; ADULT; ARTICLE; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; DOWN SYNDROME; FEMALE; FOLLOW UP; HUMAN; LANGUAGE ABILITY; LONGITUDINAL STUDY; MALE; MEMORY; MEMORY DISORDER; OXIDATIVE STRESS; PRIORITY JOURNAL; RECEPTIVE FIELD;

EID: 84865583560     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-120073     Document Type: Article

References (30)

1. Bennett S, Grant MM, Aldred S (2009) Oxidative stress in vascular dementia and Alzheimer's disease: A common pathology. J Alzheimers Dis 17, 245-257.
2. Ansari MA, Scheff SW(2010) Oxidative stress in the progression of Alzheimer disease in the frontal cortex. J Neuropathol Exp Neurol 69, 155-167.
3. Roizen NJ, PattersonD(2003)Down's syndrome. Lancet 361, 1281-1289. (Pubitemid 36428586)
4. Teipel SJ, Hampel H (2006) Neuroanatomy of Down syndrome in vivo: A model of preclinical Alzheimer's disease. Behav Genet 36, 405-415. (Pubitemid 43876779)
5. Zana M, Janka Z, Kalman J (2007) Oxidative stress: A bridge between Down's syndrome and Alzheimer's disease. Neurobiol Aging 28, 648-676. (Pubitemid 46349350)
6. Strydom A, Dickinson MJ, Shende S, Pratico D, Walker Z (2009) Oxidative stress and cognitive ability in adults with Down syndrome. Prog Neuropsychopharmacol Biol Psychiatry 33, 76-80.
7. Paglia DE, Valentine WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70, 158-169.
8. Harrison PT, Oakland T (2000) Adaptive Behaviour Assessment System (ABAS), Harcourt Assessment, USA.
9. Evenhuis HM (1996) Further evaluation of the Dementia Questionnaire for Persons with Mental Retardation (DMR). J Intel Dis Res 40, 369-373. (Pubitemid 26317071)
10. Dunn LM, DunnLM(1997) British Picture Vocabulary Scale. 2nd edition, NFER-Nelson, London.
11. Glenn S, Cunningham C (2005) Performance of young people with Down syndrome on the Leiter-R and British picture vocabulary scales. J Intel Dis Res 49, 239-244. (Pubitemid 40484964)
12. Sano M, Aisen PS, Dalton AJ, Andrews HF, Tsai W-Y, the International Down Syndrome and Alzheimer's Disease Consortium (2005) Assessment of aging individuals with down syndrome in clinical trials: Results of baseline measures. J Policy Pract Intellect Disabil 2, 126-138.
13. SPSS inc. SPSS forWindows Release 11.0.0. SPSS Inc; 2001.
14. Pastor MC, Sierra C, Dolad́e M, Navarro E, Brandi N, Cabŕe E, Mira A, Seŕes A (1998) Antioxidant enzymes and fatty acid status in erythrocytes of Down's syndrome patients. Clin Chem 44, 924-929. (Pubitemid 28213130)
15. Vilardell M, Rasche A, Thormann A, Maschke-Dutz E, Perez Jurado LA, Lehrach H, Herwig R (2011) Meta-analysis of heterogeneous Down Syndrome data reveals consistent genome-wide dosage effects related to neurological processes. BMC Genomic 12, 229.
16. Garcez ME, PeresW, SalvadorM(2005) Oxidative stress and hematologic and biochemical parameters in individuals with Down syndrome. Mayo Clin Proc 80, 1607-1611. (Pubitemid 41747063)
17. Tekşen F, Sayli BS, Aydin A, Sayal A, Işimer A (1998) Antioxidative metabolism in Down syndrome. Biol Trace Elem Res 63, 123-127. (Pubitemid 28523190)
18. Murakami K, Murata N, Noda Y, Tahara S, Kaneko T, Kinoshita N, Hatsuta H, Murayama S, Barnham KJ, Irie K, Shirasawa T, Shimizu T (2011) SOD1 deficiency drives amyloid-oligomerization and memory loss in a mouse model of Alzheimer's disease. J Biol Chem 286, 44557-44568.
19. Turner BJ, Li QX, Laughton KM, Masters CL, Lopes EC, Atkin JD, Cheema SS (2004) Brain beta-amyloid accumulation in transgenic mice expressing mutant superoxide dismutase 1. Neurochem Res 29, 2281-2286. (Pubitemid 40036901)
20. Percy ME, Dalton AJ, Markovic VD, McLachlan DR, Hummel JT, Rusk AC, Andrews DF (1990) Red cell superoxide dismutase, glutathione peroxidase and catalase in Down syndrome patients with and without manifestations of Alzheimer disease. Am J Med Genet 35, 459-467. (Pubitemid 20109002)
21. Li H, F̈orstermann U (2009) Resveratrol: A multifunctional compound improving endothelial function. Editorial to: "Resveratrol supplementation gender independently improves endothelial reactivity and suppresses superoxide production in healthy rats" by S. Soylemez et al. Cardiovasc Drugs Ther 23, 425-429.
22. Sharma M, Gupta YK (2002) Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats. Life Sci 71, 2489-2498. (Pubitemid 35251893)
23. Wang J, Ho L, Zhao W, Ono K, Rosensweig C, Chen L, Humala N, Teplow DB, Pasinetti GM (2008) Grape-derived polyphenolics prevent Abeta oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer's disease. J Neurosci 28, 6388-6392.
24. Albani D, Polito L, Batelli S, De Mauro S, Fracasso C, Martelli G, Colombo L, Manzoni C, Salmona M, Caccia S, Negro A, Forloni G (2009) The SIRT1 activator resveratrol protects SK-N-BE cells from oxidative stress and against toxicity caused by alpha-synuclein or amyloid-beta (1-42) peptide. J Neurochem 110, 1445-1456.
25. Kostapanos MS, Milionis HJ, Elisaf MS (2008) An overview of the extra-lipid effects of rosuvastatin. J Cardiovasc Pharmacol Ther 13, 157-174.
26. Lott IT, Doran E, Nguyen VQ, Tournay A, Head E, Gillen DL (2011) Down syndrome and dementia: A randomized, controlled trial of antioxidant supplementation. Am J Med Genet A 155A, 1939-1948.
27. Ellis JM, Tan HK, Gilbert RE, Muller DP, Henley W, Moy R, Pumphrey R, Ani C, Davies S, Edwards V, Green H, Salt A, Logan S (2008) Supplementation with antioxidants and folinic acid for children with Down's syndrome: Randomised controlled trial. BMJ 336, 594-597. (Pubitemid 351439516)
28. Strydom A, Shooshtari S, Lee L, Raykar V, Torr J, Tsiouris J, Jokinen N, Courtenay K, Bass N, Sinnema M, Maaskant M (2010) Dementia in older adults with intellectual disabilities-epidemiology, presentation, and diagnosis. J Policy Pract Intellect Disabil 7, 96-110.
29. De La Paz MA, Epstein DL (1996) Effect of age on superoxide dismutase activity of human trabecular meshwork. Invest Ophthalmol Vis Sci 37, 1849-1853. (Pubitemid 26265035)
30. Jang YS, Lee MH, Lee SH, Bae K (2011) Cu/Zn superoxide dismutase is differentially regulated in period gene-mutant mice. Biochem Biophys Res Commun 409, 22-27.